Winthrop P. Rockefeller Cancer Institute

September 9, 2021

UAMS Research Team Finds Potential Cause of COVID-19 ‘Long-haulers’

David Robinson

Terry Harville, M.D., Ph.D., consults with John Arthur, M.D., Ph.D., in the UAMS Pathology Lab.

LITTLE ROCK — A UAMS research team has identified a potential cause of long-lasting symptoms experienced by COVID-19 patients, often referred to as long-haulers. The findings were published in the journal, The Public Library of Science ONE (PLOS ONE). At the heart of the team’s findings is an antibody that shows up weeks after an…

August 30, 2021

New UAMS Baptist Health Cancer Center Opens in North Little Rock

Marty Trieschmann

UAMS Winthrop P. Rockefeller Cancer Institute Director Michael Birrer, M.D., Ph.D., North Little Rock Mayor Terry Hartwick, Baptist Health CEO Troy Wells, and UAMS Senior Vice Chancellor and Medical Center CEO Steppe Mette, M.D., in front of the new UAMS Baptist Health Cancer Center in North Little Rock.

LITTLE ROCK — The first UAMS Baptist Health Cancer Center is now open on the campus of Baptist Health Medical Center in North Little Rock, bringing the full spectrum of cancer research, diagnostic and treatment services available at UAMS’ Winthrop P. Rockefeller Cancer Institute to more Arkansans.

August 25, 2021

NIH Awards UAMS’ Nakagawa $3.6 Million to Expand HPV Cancer Vaccine Study

Marty Trieschmann

Dr. Mayumi Nakagawa - With an additional $3.6 million from the National Institutes of Health, Mayumi Nakagawa's, M.D., Ph.D., ground-breaking HPV vaccine research tops $10 million.

Mayumi Nakagawa, M.D., Ph.D., was awarded $3.6 million from the National Cancer Institute (NCI) to complete phase 2 clinical trials of PepCan, a breakthrough vaccine she developed at UAMS to treat cancers caused by human papillomavirus (HPV).

August 24, 2021

UAMS Winthrop P. Rockefeller Cancer Institute ‘Be a Part of the Cure’ Telethon Airs Statewide on ABC Sept. 8

Marty Trieschmann

"Be A Part of The Cure" and text or call in your donation in support of our cancer research efforts.

Arkansans are invited to “Be a Part of the Cure” on Sept. 8 when the Winthrop P. Rockefeller Cancer Institute at the University of Arkansas for Medical Sciences (UAMS) holds its second televised event to raise funds and awareness for its cancer research and treatment programs. The event is set for 11 a.m. – 6:30…

August 19, 2021

UAMS Researcher Leading $3.1 Million Preschool Intervention to Reduce Obesity and Cancer in Arkansas, Louisiana

David Robinson

Taren Swindle, Ph.D., here visiting a Head Start classroom in 2019, is leading the NCI-funded study that aims to improve diets in early care and education settings.

UAMS is leading a major new effort to reduce cancer by addressing eating habits in early childcare and education settings. The project, led by UAMS’ Taren Swindle, Ph.D., will reach about 5,000 children and 500 teachers across Arkansas and Louisiana.

August 10, 2021

Samer Al Hadidi, M.D., Joins the UAMS Myeloma Center

Linda Haymes

Samer Al Hadidi, M.D.

LITTLE ROCK — Samer Al Hadidi, M.D., has joined the Myeloma Center in the Winthrop P. Rockefeller Cancer Institute at the University of Arkansas for Medical Sciences (UAMS), where he will treat patients with myeloma and other plasma cell disorders. “I’m very happy to welcome Dr. Al Hadidi to our staff,” said Frits van Rhee,…

August 9, 2021

UAMS Offering Revolutionary CAR T-Cell Therapy for Myeloma Patients

Linda Haymes

“This offers an entirely new treatment option for relapsed myeloma patients,” said Myeloma Center clinical director Frits van Rhee, M.D., Ph.D. “It is a whole new class of treatment; it’s like immunotherapy is coming of age.”

The Myeloma Center at the UAMS Winthrop P. Rockefeller Cancer Institute is offering a new cutting-edge immunotherapy treatment for myeloma patients. The University of Arkansas for Medical Sciences (UAMS) is the first and only medical facility in Arkansas approved to provide cellular therapy to myeloma patients.

July 22, 2021

UAMS Performs First GammaTile Brain Surgery in Arkansas

Spencer Watson

UAMS surgeons prepare to perform the first surgery in Arkansas using GammaTile Therapy or surgically targeted radiation therapy.

LITTLE ROCK — Radiation oncologist  Richard Crownover, M.D., Ph.D., and neurosurgeon Analiz Rodriguez, M.D., Ph.D., and their care team at the University of Arkansas for Medical Sciences (UAMS) have performed the state’s first application of GammaTile Therapy.

July 21, 2021

Cancer Discovery Published in Nature Highlights National Role of UAMS Research Team

David Robinson

Members of the UAMS proteomics team are Alan Tackett, Ph.D. (center front), and (l-r) Stephanie Byrum, Ph.D., Rick Edmondson, Ph.D., Aaron Storey, Ph.D., and Samuel Mackintosh, Ph.D.

LITTLE ROCK — A highly specialized UAMS research team that serves as a national resource recently helped the University of North Carolina (UNC) discover a key driver of cancer cell development. The discovery, which gives researchers around the globe a new target for drug therapies, was published in the journal Nature. The achievement put an…

July 16, 2021

Michael Birrer, M.D., Ph.D., Invested in Kent C. Westbrook, M.D. Director’s Chair for the Winthrop P. Rockefeller Cancer Institute

Benjamin Waldrum

UAMS Executive Vice Chancellor and College of Medicine Dean Susan Smyth, M.D., and UAMS Chancellor Cam Patterson, M.D., MBA, present Birrer (seated) with his commemorative medallion and inscribed wooden chair.

LITTLE ROCK — Michael Birrer, M.D., Ph.D., vice chancellor and director of the Winthrop P. Rockefeller Cancer Institute at the University of Arkansas for Medical Sciences (UAMS), was invested July 15 in the Kent C. Westbrook, M.D. Director’s Chair for the Winthrop P. Rockefeller Cancer Institute. “Michael Birrer’s scholarly corpus is incredibly impressive, and the…


Previous page Next page